Effects of Paricalcitol and Enalapril on Atherosclerotic Injury in Mouse Aortas

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Nephrology

• Publication date

  2010-08-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000319445PMID 20720404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.

  2010cited by this paper
• Lipoic acid effects on established atherosclerosis.

  2010cited by this paper
• Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis.

  2010cited by this paper
• Vitamin D and the cardiovascular system.

  2009cited by this paper
• Vitamin D and cardiovascular disease.

  2009cited by this paper
• Vitamin D Deficiency and Risk for Cardiovascular Disease

  2009cited by this paper
• Angiotensin-converting enzyme inhibitors and atherosclerotic plaque: a key role in the cardiovascular protection of patients with coronary artery disease

  2009cited by this paper
• Effects of Oral Estrogen on Aortic ROS-Generating and -Scavenging Enzymes and Atherosclerosis in apoE-Deficient Mice

  2009cited by this paper
• Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease: A Randomized Double-Blind Pilot Trial

  2008cited by this paper
• Combination Therapy with Paricalcitol and Enalapril Ameliorates Cardiac Oxidative Injury in Uremic Rats

  2008cited by this paper
• Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

  2008cited by this paper
• Vitamin D receptor activators can protect against vascular calcification.

  2008cited by this paper
• Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.

  2008cited by this paper
• Vitamin D Deficiency and Risk of Cardiovascular Disease

  2008cited by this paper
• Vascular endothelial oxidative stress in alcohol-induced hypertension.

  2007cited by this paper
• 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells.

  2007cited by this paper
• Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol.

  2007cited by this paper
• Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

  2007cited by this paper
• Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.

  2006cited by this paper
• Renin-Angiotensin System Modulates Oxidative Stress–Induced Endothelial Cell Apoptosis in Rats

  2005cited by this paper
• Analogs of 1α,25-dihydroxyvitamin D3 as novel inhibitors of renin biosynthesis

  2005cited by this paper
• The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.

  2005cited by this paper
• Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?

  2005cited by this paper
• A New Cellular Signaling Mechanism for Angiotensin II Activation of NF-&kgr;B: An I&kgr;B–Independent, RSK–Mediated Phosphorylation of p65

  2005cited by this paper
• Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation.

  2005cited by this paper
• Vitamin E, oxidative stress, and inflammation.

  2005cited by this paper
• A New Cellular Signaling Mechanism for Angiotensin II Activation of NF-κB

  2005cited by this paper
• RETRACTED ARTICLE: Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats

  2005cited by this paper
• Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis.

  2005cited by this paper
• Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system.

  2004cited by this paper
• The Renin‐Angiotensin‐Aldosterone System: Cardiorenal Effects and Implications for Renal and Cardiovascular Disease States

  2003cited by this paper
• Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

  2003cited by this paper
• Role of the Intronic Enhancer in Tumor Necrosis Factor-mediated Induction of Manganous Superoxide Dismutase*

  2003cited by this paper
• 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

  2002cited by this paper
• 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

  2002cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Angiotensin II–Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice

  2001cited by this paper
• Transcription factor-kappa B (NF-kappa B) and renal disease.

  2001cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• The multiple actions of angiotensin II in atherosclerosis.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats.

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

  1999cited by this paper
• Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy.

  1998cited by this paper
• Nitric oxide synthases: which, where, how, and why?

  1997cited by this paper
• Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective.

  1995cited by this paper
• Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.

  1994cited by this paper
• Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts.

  1992cited by this paper
• Ethanol toxicity and oxidative stress.

  1992cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation.

  1990cited by this paper
• Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein.

  1981cited by this paper
• Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo.

  1981cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979influential reference
• Captopril in the treatment of clinical hypertension and cardiac failure.

  1979cited by this paper

• Combination therapy and drug co-delivery systems for atherosclerosis.

  2025cites this paper
• Possible role of LCZ696 in atherosclerosis: new inroads and perspective

  2023cites this paper
• Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases

  2023cites this paper
• Combination Therapy with Enalapril and Paricalcitol Ameliorates Streptozotocin Diabetes-Induced Testicular Dysfunction in Rats via Mitigation of Inflammation, Apoptosis, and Oxidative Stress

  2023cites this paper
• Ferrotoxicity and Its Amelioration by Calcitriol in Cultured Renal Cells

  2021cites this paper
• "Evaluation of Enzymes Involved in the Production of Endogenous Reactive Oxygen Species and Role of Long-term Oxidative Stress in Pathobiology of Atherosclerosis with Common Oxidative Stress Markers"

  2021cites this paper
• Research progress in the pharmacological actions of the multiple effects and selectivity of the vitamin D analogue paricalcitol: a narrative review.

  2021cites this paper
• The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases

  2020cites this paper
• Effects of vitamin D on drugs: Response and disposal.

  2020cites this paper
• Interplay Between Oxidative Stress, Cyclooxygenases, and Prostanoids in Cardiovascular Diseases

  2020cites this paper
• Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways.

  2020cites this paper
• Effects of Glucagon-like Peptide-1 Analogues and Dipeptidyl Peptidase-IV Inhibitors on Hepatic Oxidative Stress and Non-Alcoholic Steatohepatitis in Male Albino Rats

  2020cites this paper
• Ferrotoxicity and its amelioration by endogenous vitamin D in experimental acute kidney injury

  2020cites this paper
• Role of Paricalcitrol as an Active Vitamin D Analogue on Erectile Function and Penile NOS Expression in Diabetic Rats

  2019cites this paper
• Ameliorative effects of paricalcitol against 1800-MHz mobile phone radiation-induced skin damage in rats

  2019cites this paper
• Effect of low‐level 1800 MHz radiofrequency radiation on the rat sciatic nerve and the protective role of paricalcitol

  2018cites this paper
• Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats

  2018cites this paper
• Effect of paricalcitol on pancreatic oxidative stress, inflammatory markers, and glycemic status in diabetic rats

  2018cites this paper
• The potential therapeutic use of renin–angiotensin system inhibitors in the treatment of inflammatory diseases

  2018cites this paper
• Brief Communication: Plasma lipid oxidation predicts atherosclerotic status better than cholesterol in diabetic apolipoprotein E deficient mice

  2017cites this paper
• The Toxicity of Iodinated Radiographic Contrast Agents in the Clinical Practice

  2017cites this paper
• The protective role of vitamin D on the heart and the kidney

  2017cites this paper
• Mineral metabolism and cardiovascular disease in CKD

  2017cites this paper
• Unknown face of known drugs – what else can we expect from angiotensin converting enzyme inhibitors?

  2017cites this paper
• oxidative stress in uremic rats activator on glomerulosclerosis, proteinuria, and renal Effect of combining an ACE inhibitor and a VDR

  2016cites this paper
• Assesment of Microcirculatory Function with Retrobulbar Blood Flow Velocity Measurement Predicting Cardiovascular Events

  2016cites this paper
• The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism.

  2016cites this paper
• Efectos pleiotrópicos del paricalcitol: más allá del metabolismo óseo-mineral

  2016cites this paper
• Thyroid Hormones, Oxidative Stress, and Inflammation

  2016cites this paper
• Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model

  2016cites this paper
• ReviewThe pleiotropic effects of paricalcitol: Beyond bone-mineral metabolismEfectos pleiotrópicos del paricalcitol, más allá del metabolismo óseo-mineral☆

  2016cites this paper
• 25-hydroxy vitamin D and ischaemia-modified albumin levels in psoriasis and their association with disease severity

  2015cites this paper
• Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.

  2015cites this paper
• Effect of paricalcitol and enalapril on renal inflammation/oxidative stress in atherosclerosis.

  2015cites this paper
• Original articleThe effect of some medications given to CKD patients on vitamin D levelsEfectos de algunos fármacos administrados a los pacientes de ERC sobre los niveles de vitamina D

  2015cites this paper
• The effect of some medications given to CKD patients on vitamin D levels.

  2015cites this paper
• Effect of combining an angiotensin-converting enzyme inhibitor and a vitamin D receptor activator on renal oxidative and nitrosative stress in diabetic rats

  2015cites this paper
• Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice

  2014cites this paper
• Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial.

  2014cites this paper
• Biomarkers Part II: Biomarkers to Estimate Bioefficacy of Dietary/Supplemental Antioxidants in Sport

  2014cites this paper
• Emerging Aspects of Angiotensin Biology and Their Potential Role in the Vasculature

  2014cites this paper
• VitaminD Receptor Activators and Clinical Outcomes in Chronic Kidney Disease

  2014cites this paper
• Vitamin D receptor-modulated Hsp70/AT1 expression may protect the kidneys of SHRs at the structural and functional levels

  2014cites this paper
• [Mitochondria and oxidative stress participation in renal inflammatory process].

  2014cites this paper
• Clinical Uses of 1,25-dihydroxy-19-nor-vitamin D(2) (Paricalcitol).

  2014cites this paper
• Reprint of: Vitamin D receptor activation and prevention of arterial ageing.

  2013cites this paper
• The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms

  2013cites this paper
• The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection

  2013cites this paper
• The Role of Vitamin D in Primary Biliary Cirrhosis: Possible Genetic and Cell Signaling Mechanisms

  2013cites this paper
• The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.

  2013cites this paper
• The beneficial role of vitamin D in human immunodeficiency virus infection.

  2013cites this paper
• Vitamin D and inflammation

  2013cites this paper
• Anti-Oxidative Effect of Vitamin D Analog on Incipient Vascular Lesion in Non-Obese Type 2 Diabetic Rats

  2013cites this paper
• Paricalcitol reduces proteinuria but does not modify peritoneal protein loss in patients on peritoneal dialysis.

  2013cites this paper
• Double treatment with paricalcitol-associated calcifediol and cardiovascular risk biomarkers in haemodialysis.

  2013cites this paper
• The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms

  2013cites this paper
• Vitamin D and Parkinson's disease.

  2012cites this paper
• Targeting NADPH oxidases in vascular pharmacology.

  2012cites this paper
• Vitamin D and Oxidative Stress

  2012cites this paper
• Vitamin D receptor activation and cardiovascular disease.

  2012cites this paper
• Role of mitochondria in paricalcitol-mediated cytoprotection during obstructive nephropathy.

  2012cites this paper
• Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats.

  2012cites this paper
• Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients

  2012cites this paper
• Full Review Vitamin D receptor activation and cardiovascular disease

  2012cites this paper
• Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress.

  2012cites this paper
• Vitamin D receptor activation and prevention of arterial ageing.

  2012cites this paper
• Theoretical basis of a beneficial role for vitamin D in viral hepatitis.

  2012cites this paper
• Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model.

  2012cites this paper
• Low-dose calcitriol decreases aortic renin, blood pressure, and atherosclerosis in apoe-null mice.

  2012cites this paper
• The beneficial role of vitamin D in systemic lupus erythematosus (SLE)

  2012cites this paper
• Apoptosis modulated by oxidative stress and inflammation during obstructive nephropathy.

  2012influential citation
• Vitamin D and Parkinson's disease

  2012cites this paper
• Vitamin D — which, whom and why?

  2011cites this paper
• The Beneficial Role of Vitamin D in Alzheimer’s Disease

  2011cites this paper
• Does any therapy exist for vascular calcifications in uremia?

  2011cites this paper
• Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice.

  2011cites this paper
• Vitamin D Receptor Activators and Clinical Outcomes in Chronic Kidney Disease

  2011cites this paper
• Treatment of cardiovascular calcification in uremia.

  2011cites this paper
• Vascular Dysfunction , Atherosclerosis , and Vascular Calcification Insights and Implications in Chronic Kidney Disease

  2010cites this paper
• The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system

  year unknowncites this paper